PRELUENT
Dead / Cancelled — Cancelled — Section 8 (as of 19 Feb 2021)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86019033
- Registration number
- 4566771
- Mark type
- Stylized text
- Filed
- 24 Jul 2013
- Published for opposition
- 29 Apr 2014
- Registered
- 15 Jul 2014
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; vitamins being pharmaceutical preparations; hormone preparations being pharmaceutical preparations for medical purposes
Owner
- SANOFI BIOTECHNOLOGY, 75008 PARIS, FR
- Sanofi, Paris, FR
- Sanofi, Paris, FR
- Sanofi, Paris, FR
Prior registrations
Prosecution history
- 19 Feb 2021 — CANCELLED SEC. 8 (6-YR)
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Jul 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Oct 2015 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 15 Jul 2014 — REGISTERED-PRINCIPAL REGISTER
- 29 Apr 2014 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Apr 2014 — PUBLISHED FOR OPPOSITION
- 09 Apr 2014 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Mar 2014 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 14 Mar 2014 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Mar 2014 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Mar 2014 — CORRESPONDENCE RECEIVED IN LAW OFFICE